5382 J. Am. Chem. Soc., Vol. 120, No. 22, 1998
Winter et al.
Scheme 1. Chemical Structure and Atom Numbering of the
Scheme 2. Schematic Drawing of the Two Hybrid
Anhydrohexitol Nucleosides Used in This Studya
Complexes Used in This Studya
a The lowercase letter at the beginning of each residue name stands
for the particular residue type: ‘h’ for anhydrohexitol, ‘d’ for
deoxyribose, and ‘r’ for ribose. The residue numbering starts at the
7′-terminal side of the HNA chain and ends at the 3′-end of the DNA
(HNA/DNA complex) or RNA strand (HNA/RNA complex). Residue
12 can be either thymidine (HNA/DNA duplex) or uridine (HNA/RNA
duplex). The black boxes linking adjacent nucleotides indicate phos-
phodiester bridges, and hydrogen bonds between opposite residues are
drawn by thin lines.
a The base moiety can be adenine, guanine, cytosine, or thymine.
Methods
Nomenclature. The chemical structure and atom naming of
anhydrohexitol nucleosides as used throughout the modeling and NMR
experiments is given in Scheme 1. They are composed of a six-
membered anhydrohexitol ring that is substituted at C1′ by one of the
four different heterocycles attached by a C1′-N linkage. The
heterocycles are the purine bases adenine (A) and guanine (G) and the
pyrimidine bases cytosine (C) and thymine (T). In anhydrohexitol
oligonucleotides (HNA), the individual anhydrohexitol residues are
linked via 3′,7′-phosphodiester bonds. Such HNA oligonucleotides can
form antiparallel duplexes with DNA or RNA oligonucleotides, and
the general structure of the two hybrid complexes used in the present
study are shown in Scheme 2.
(C-6′), 64.2 (C-4′, d, J ) 3.8 Hz), 68.4 (C-1′), 80.4 (C-5′, d, J ) 8
Hz), 86.2 (Ph3C), 110.5 (C-5), 138.5 (C-6), 151.2 (C-2), 163.9 (C-4),
113.0, 126.8, 127.4, 127.7, 130.4, 135.5, 144.3, 158.4 (aromatic C)
ppm.
1,5-Anhydro-4-O-benzoyl-2-(N6-benzoyladenin-9-yl)-2,3-dideoxy-
D-arabino-hexitol (2b). An amount of 257 mg (0.4 mmol) of 1b12
was co-evaporated with pyridine and subsequently dissolved in 20 mL
of anhydrous pyridine after which 110 µL (0.8 mmol) of benzoyl
chloride was added. The mixture was stirred overnight at room
temperature and quenched with 2 mL of methanol. After addition of
some NaHCO3, the mixture was concentrated and partitioned between
CH2Cl2 and 5% of aqueous NaHCO3. The organic phase was washed
once more with 75 mL of aqueous NaHCO3 and dried on Na2SO4.
Evaporation left an oil that was co-evaporated with toluene. The foam
was treated with 40 mL of 80% aqueous HOAc and left at RT for 1 h.
Evaporation gave 400 mg of a light brown foam that was purified on
silica gel with a methanol gradient in CH2Cl2 (100 to 96:4). The
product-containing fractions were pooled affording 86 mg (0.18 mmol,
45%) of the title product 2b as a white powder. LSIMS (ThGLy) m/z
474 (MH+, 25), 240 (BH2+, 7). 1H NMR (CDCl3): δ 2.21-2.39 (ddd,
1H, H-3′ax), 2.84-2.98 (dm, J ) 13.5 Hz, 1H, H-3”eq), 3.64-3.91 (m,
3H, H-5′, H-6′, H-6”), 4.13 (dd, 1H, J ) 2.6 and 13.1 Hz, H-1′ax),
4.52 (dm, 1H, J ) 12.5 Hz, H-1′eq), 5.07-5.14 (m, 1H, H-2′), 5.18-
5.33 (m, 1H, H-4′), 7.35-7.65 (m, 6H, aromatic H), 7.91-8.08 (m,
4H, aromatic H), 8.70 (s, 1H) and 8.80 (s, 1H) (H-2, H-8), 9.63 (br s,
1H, NH) ppm. 13C NMR (CDCl3): δ 33.1 (C-3′), 50.7 (C-2′), 61.4
(C-6′), 64.4 (C-4′), 69.1 (C-1′), 80.5 (C-5′), 123.2 (C-5), 142.0 (C-8),
149.6 (C-4), 151.7 (C-6), 152.5 (C-2), 164.8, 165.4 (2 × CO) ppm +
aromatic signals.
Synthesis
1,5-Anhydro-6-O-monomethoxytrityl-2-(thymin-1-yl)-2,3-dideoxy-
D-arabino-hexitol-4-yl-hydrogenphosphonate, Triethylammonium
Salt (3a). To 270 µL (3 mmol) of phosphorus trichloride in 30 mL of
anhydrous CH2Cl2 cooled on an icebath was added 3.3 mL (30 mmol)
of N-methylmorpholine and 690 mg (10 mmol) of 1,2,4-triazole. The
mixture was stirred for 30 min at room temperature and subsequently
cooled again, and 320 mg (0.6 mmol) of 1,5-anhydro-6-O-monomethoxy-
trityl-2-(thymin-1-yl)-2,3-dideoxy-D-arabino-hexitol (1a)12 dissolved in
10 mL of CH2Cl2 was added dropwise over 15 min. The mixture was
stirred for 10 min more at room temperature and poured into 25 mL of
1 M triethylammonium bicarbonate (TEAB) buffer. After separation
of both layers, the aqueous phase was extracted once more with CH2Cl2,
and the organics were dried and purified by flash chromatography on
20 g of silica gel (gradient of CH2Cl2-TEA 99:1 to CH2Cl2-TEA-
MeOH 89:1:10). Product-containing fractions were washed once with
25 mL of 1 M TEAB buffer and dried, affording 344 mg (0.495 mmol,
82%) of the title product 3a as a white foam. LSIMS (ThGly doped
with NaOAc) m/z 659 (M + 3Na+, 1), 637 (M + 2Na+, 2), 273
(MMTr+, 100). 1H NMR (CDCl3): δ 1.27 (t, 9H, J ) 7 Hz, CH2CH3),
1.74 (s, 3H, CH3), 1.94-2.11 (m, 1H, H-3′ax), 2.61 (dm, 1H, H-3′′eq),
3.00 (q, 6H, CH2CH3), 3.34 (dd, 1H, J ) 4.5 and 10.4 Hz, H-5′), 3.45-
3.60 (m, 2H, H-6′, H-6”), 3.79 (s, 3H, OCH3), 3.89 (dd, 1H, J ) 3.4
and 13.4 Hz, H-1′ax), 4.16 (d, 1H, J ) 13.6 Hz, H-1′eq), 4.57 (m, 1H,
H-4′), 4.73 (m, 1H, H-2′), 6.66 (d, 1H, J ) 625 Hz, P-H), 6.83 (d, J
) 8.7, 2H, aromatic H), 7.15-7.55 (m, 12H, aromatic H), 8.05 (s, 1H,
H-6), 9.50 (br s, 1H, NH) ppm. 13C NMR (CDCl3): δ 8.5 (CH2CH3),
12.7 (CH3), 35.2 (C-3′), 45.3 (CH2CH3), 50.4 (C-2′), 55.1 (OCH3), 62.7
[1,5-Anhydro-2-(thymin-1-yl)-2,3-dideoxy-D-arabino-hexitol]-(4-
6)-[1,5-anhydro-2-(adenin-9-yl)-2,3-dideoxy-D-arabino-hexitol]phos-
phate, Sodium Salt (5). A portion of 86 mg (0.18 mmol) of 2b and
145 mg (0.21 mmol) of the thymine hydrogenphosphonate 3a were
co-evaporated twice with anhydrous pyridine and dissolved in a 6 mL
mixture of anhydrous pyridine and acetonitrile. One milliliter (0.5
mmol) of a dilution of pivaloyl chloride in pyridine was added, and
the reaction mixture was stirred for 10 min at room temperature under
a nitrogen atmosphere. Subsequently 2 mL of a 4% I2 (w/v) solution
in pyridine-water (96:4) was added, and stirring continued for another
10 min at room temperature. The mixture was diluted with 100 mL
(12) De Bouvere, B.; Kerremans, L.; Rozenski, J.; Janssen, G.; Van
Aerschot, A.; Claes, P.; Busson, R.; Herdewijn, P. Liebigs Ann. 1997, 1453-
1461.